Clinical course of the syndrome of autoantibodies to the insulin receptor (type B insulin resistance): a 28-year perspective.
Arioglu
Elif
E
Diabetes Branch, National Institute of Diabetes, Digestive and Kidney Diseases (NIDDK), National Institutes of Health, Bethesda, Maryland 20892-1829, USA.
Andewelt
Alexa
A
Diabo
Crystal
C
Bell
Melissa
M
Taylor
Simeon I
SI
Gorden
Phillip
P
D000052:Acanthosis Nigricans / Q000209:etiology; D000293:Adolescent; D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000328:Adult; D000368:Aged; D001327:Autoimmune Diseases / Q000150:complications / Q000401:mortality / Q000503:physiopathology / Q000628:therapy; D001823:Body Composition; D002423:Cause of Death; D002648:Child; D005260:Female; D006801:Humans; D017588:Hyperandrogenism / Q000209:etiology; D006943:Hyperglycemia / Q000209:etiology / Q000628:therapy; D007003:Hypoglycemia / Q000209:etiology / Q000628:therapy; D007004:Hypoglycemic Agents / Q000627:therapeutic use; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007333:Insulin Resistance; D008297:Male; D008875:Middle Aged; D010956:Plasmapheresis; D011972:Receptor, Insulin / Q000276:immunology*; D012189:Retrospective Studies; D013577:Syndrome; D014481:United States / Q000453:epidemiology
D000305:Adrenal Cortex Hormones; D007004:Hypoglycemic Agents; D007166:Immunosuppressive Agents; D011972:Receptor, Insulin